SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : North American Vaccine
NVX 0.931-4.1%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rick Strange who wrote (175)12/16/1997 8:56:00 AM
From: Don W Stone  Read Replies (2) of 507
 
Rick: You said : <<<<I think that you would be wise to back off of your unsubstantiated
claims that formaldehyde inactivated toxoids cause side-effects>>>.

I never said that formaldehyde caused side-effects. I am conveying what is presented in the NVX literture that formaldehyde is a less desirable way to inactivate the pertussis toxoid than the way NVX did with Certiva. It may be all right with D and T. Exactly why I don't know. If you are a microbiologist perhaps you could elaborate for us.
From what you are saying are you implying that the Adverse Events that the others are having is perhaps due to the other components that they have added?
Actually , I don't care if they all used lemon juice if it gets the desired results.

Bottomline is NVX's CERTIVA is a lot safer vaccine than any of the DTaP vaccines that are now on the market. With in excess of 200,000 doses administered they have experienced ZERO Adverse Events. Tough record to beat wouldn't you say? How do you account for that?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext